Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Articufit is a multi-ingredient dietary supplement formulated to support joint health, flexibility, and bone integrity. It is developed by the French company Santé Verte and distributed in markets such as Hong Kong by Reich Pharma. The product typically contains a combination of structural components of cartilage, such as glucosamine sulfate and chondroitin sulfate, alongside botanical extracts known for their anti-inflammatory properties, including devil's claw (*Harpagophytum procumbens*) and turmeric (*Curcuma longa*). Additionally, it often includes essential minerals like manganese and copper, which contribute to the maintenance of normal connective tissues and bone health. Articufit is intended for individuals seeking to alleviate joint discomfort or maintain mobility through nutritional support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Articufit.